Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...
Daily2d
Sun Pharma Lab gets CDSCO Panel nod to conduct Phase III CT of Semaglutide solution for injection
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
HRS: Boost your metabolic & GDP health for a stronger new year
Redmond, founder and CEO of Dr. Stephanie’s Supplements, showcased her products, which she described as the latest innovations in supplement options for hormone and metabolic health, including a ...
Whose cardiovascular health do SGLT2, GLP-1 diabetes drugs benefit most?
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
Medscape4d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1 ... while the inhibition of α-cell secretion has received less attention. The aim of this research was to quantify the glucagonostatic contribution ...
Medscape2d
Dipeptidyl Peptidase-4 Inhibitors: Clinical Data and Clinical Implications
Several DPP-4 inhibitors are in clinical development; these are orally active and increase levels of active GLP-1, which in turn increases insulin secretion and reduces glucagon secretion and ...
Hosted on MSN2d
How Weight Loss Drugs Change Ones Relationship With Food?
For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors ...
Frontiers3d
Endocrine disorders and fertility and pregnancy: An update
It is estimated that more and more couples suffer from fertility and pregnancy maintenance disorders. It is associated with impaired androgen secretion, which is influenced by many factors, ranging ...